Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)
- DOI
- 10.1016/j.clcc.2020.01.003
- Published
- 2020-06
- Container
- Clinical Colorectal Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.clcc.2020.01.003,
title = {Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)},
author = {Evaristo Maiello and Gabriele Di Maggio and Stefano Cordio and Saverio Cinieri and Francesco Giuliani and Salvatore Pisconti and Antonio Rinaldi and Antonio Febbraro and Tiziana Pia Latiano and Michele Aieta and Antonio Rossi and Daniele Rizzi and Massimo Di Maio and Giuseppe Colucci and Roberto Bordonaro},
year = {2020},
journal = {Clinical Colorectal Cancer},
doi = {10.1016/j.clcc.2020.01.003},
url = {https://doi.org/10.1016/j.clcc.2020.01.003}
}RIS
TY - JOUR TI - Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802) AU - Evaristo Maiello AU - Gabriele Di Maggio AU - Stefano Cordio AU - Saverio Cinieri AU - Francesco Giuliani AU - Salvatore Pisconti AU - Antonio Rinaldi AU - Antonio Febbraro AU - Tiziana Pia Latiano AU - Michele Aieta AU - Antonio Rossi AU - Daniele Rizzi AU - Massimo Di Maio AU - Giuseppe Colucci AU - Roberto Bordonaro PY - 2020 JO - Clinical Colorectal Cancer DO - 10.1016/j.clcc.2020.01.003 UR - https://doi.org/10.1016/j.clcc.2020.01.003 ER -
APA
Maiello, E., Maggio, G. D., Cordio, S., Cinieri, S., Giuliani, F., Pisconti, S., Rinaldi, A., Febbraro, A., Latiano, T. P., Aieta, M., Rossi, A., Rizzi, D., Maio, M. D., Colucci, G., & Bordonaro, R. (2020). Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802). Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2020.01.003
Source records
- crossref · retrieved 2026-09-26T17:00:12.931Z